Abstract
The high prevalence of hepatitis C virus infection explains why not negligible proportions of candidates for hematopoietic stem cell transplantation have this infection. In this perspective article, Dr. Socié and colleagues discuss the clinical problems that derive from hepatitis C virus in transplant recipients. See related article on page 249.